{"cluster": 58, "subcluster": 0, "abstract_phrases": [{"text": "lopinavir-ritonavir trial", "rank": 0.082}, {"text": "covid-19 trials", "rank": 0.081}, {"text": "clinical trials", "rank": 0.077}, {"text": "randomized clinical trials", "rank": 0.073}, {"text": "remdesivir trial", "rank": 0.073}], "title_phrases": [{"text": "covid-19 clinical trials", "rank": 0.2}, {"text": "clinical trials", "rank": 0.162}, {"text": "covid-19", "rank": 0.156}, {"text": "a dynamic systematic benefit-risk assessmentstatistical issues", "rank": 0.133}, {"text": "lessons", "rank": 0.131}], "title_abstract_phrases": [{"text": "covid-19 trials", "rank": 0.084}, {"text": "lopinavir-ritonavir trial", "rank": 0.081}, {"text": "clinical trials", "rank": 0.076}, {"text": "remdesivir trial", "rank": 0.072}, {"text": "randomized clinical trials", "rank": 0.072}]}